Showing results (2241-2250 of 4,138) with videos related to
Sort By:
Pageof 414
Human Gene Therapy|April 1, 1995
Enhancement of interleukin-4-mediated tumor regression in athymic mice by in situ retroviral gene transferM X Wei, T Tamiya, R K Hurford, et al.Human Gene Therapy|December 1, 1995
Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutantsV Krougliak, F L GrahamHuman Gene Therapy|September 1, 1995
A plasmid-based self-amplifying Sindbis virus vectorH Herweijer, J S Latendresse, P Williams, et al.Human Gene Therapy|September 1, 1995
Efficiency of in vivo gene transfer using murine retroviral vectors is strain-dependent in miceA Fassati, D J Wells, F S Walsh, et al.Human Gene Therapy|September 1, 1995
Stereotactic injection of herpes simplex thymidine kinase vector producer cells (PA317-G1Tk1SvNa.7) and intravenous ganciclovir for the treatment of progressive or recurrent primary supratentorial pediatric malignant brain tumorsL E Kun, A Gajjar, M Muhlbauer, et al.Human Gene Therapy|June 1, 1993
Studies on the safety of intrasplenic hepatocyte transplantation: relevance to ex vivo gene therapy and liver repopulation in acute hepatic failureS Gupta, P R Yerneni, R P Vemuru, et al.Human Gene Therapy|April 10, 1996
Consistent and high rates of gene transfer can be obtained using flow-through transduction over a wide range of retroviral titersA S Chuck, B O PalssonHuman Gene Therapy|October 1, 1996
Cancer gene therapy using tumor cells infected with recombinant vaccinia virus expressing GM-CSFH Qin, S K ChatterjeeHuman Gene Therapy|October 1, 1996
Retroviral vectors efficiently transduce basal and secretory airway epithelial cells in vitro resulting in persistent gene expression in organotypic cultureC L Halbert, M L Aitken, A D MillerHuman Gene Therapy|October 1, 1996
In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genesS E Haecker, H H Stedman, R J Balice-Gordon, et al.Pageof 414